These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 29055921)
1. Hepatitis C and Its Metabolic Complications in Kidney Disease. Fabrizi F; Donato FM; Messa P Ann Hepatol; 2017 November-December,; 16(6):851-861. PubMed ID: 29055921 [TBL] [Abstract][Full Text] [Related]
2. Association Between Hepatitis C Virus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Fabrizi F; Donato FM; Messa P Ann Hepatol; 2018; 17(3):364-391. PubMed ID: 29735788 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus and mortality among patients on dialysis: A systematic review and meta-analysis. Fabrizi F; Dixit V; Messa P Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):244-254. PubMed ID: 30910601 [TBL] [Abstract][Full Text] [Related]
4. [Direct-acting antiviral agents, hepatitis C and dialysis: an update]. Fabrizi F; Lampertico P; Messa P G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234230 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy. Sagnelli E; Stroffolini T; Sagnelli C; Cacopardo B; Andriulli A; Babudieri S; Coppola N; Gaeta GB; Almasio PL Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):676-681. PubMed ID: 29465473 [TBL] [Abstract][Full Text] [Related]
6. Recent advances on hepatitis C virus in dialysis population. Fabrizi F; Messa P; Martin P Kidney Blood Press Res; 2014; 39(4):260-71. PubMed ID: 25171295 [TBL] [Abstract][Full Text] [Related]
7. Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality? Fabrizi F; Dixit V; Messa P J Viral Hepat; 2012 Sep; 19(9):601-7. PubMed ID: 22863263 [TBL] [Abstract][Full Text] [Related]
8. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN). Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL; ; ; ; J Nephrol; 2018 Oct; 31(5):685-712. PubMed ID: 30255440 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C-related liver disease in dialysis patients. Fabrizi F; Dixit V; Messa P; Martin P Contrib Nephrol; 2012; 176():42-53. PubMed ID: 22310780 [TBL] [Abstract][Full Text] [Related]
10. Clinical Findings of HCV Chronic Infection in Undocumented Immigrants and Low-Income Refugees in Three Areas of Southern Italy. Sagnelli E; Alessio L; Sagnelli C; Gualdieri L; Pisaturo M; Minichini C; Di Caprio G; Starace M; Onorato L; Scotto G; Macera M; Coppola N Ann Hepatol; 2018; 17(1):47-53. PubMed ID: 29311411 [TBL] [Abstract][Full Text] [Related]
11. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study. Giordanino C; Bugianesi E; Smedile A; Ciancio A; Abate ML; Olivero A; Pellicano R; Cassader M; Gambino R; Bo S; Ciccone G; Rizzetto M; Saracco G Am J Gastroenterol; 2008 Oct; 103(10):2481-7. PubMed ID: 18702647 [TBL] [Abstract][Full Text] [Related]
12. Safety and effectiveness of response-guided therapy using pegylated interferon and ribavirin for chronic hepatitis C virus infection in patients on maintenance dialysis. Goel A; Bhadauria DS; Kaul A; Prasad N; Gupta A; Sharma RK; Rai P; Aggarwal R Nephrology (Carlton); 2017 Sep; 22(9):706-711. PubMed ID: 27286895 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology of hepatitis C virus infection in hemodialysis patients of Sicily. Montalto G; Li Vecchi M; Sesti R; Santoro D; Savica V; Bellinghieri G Int J Artif Organs; 2008 Aug; 31(8):745-6. PubMed ID: 18825649 [No Abstract] [Full Text] [Related]
14. Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies. Petta S; Maida M; Macaluso FS; Barbara M; Licata A; Craxì A; Cammà C Gastroenterology; 2016 Jan; 150(1):145-155.e4; quiz e15-6. PubMed ID: 26386298 [TBL] [Abstract][Full Text] [Related]
15. Confluence of Epidemics of Hepatitis C, Diabetes, Obesity, and Chronic Kidney Disease in the United States Population. Lazo M; Nwankwo C; Daya NR; Thomas DL; Mehta SH; Juraschek S; Willis K; Selvin E Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1957-1964.e7. PubMed ID: 28579183 [TBL] [Abstract][Full Text] [Related]
16. Impact of antiviral therapy with direct acting antiviral agents (DAAs) on kidney disease in patients with chronic hepatitis C. Fabrizi F; Cerutti R; Alfieri CM; Ridruejo E Minerva Gastroenterol (Torino); 2021 Sep; 67(3):244-253. PubMed ID: 33793155 [TBL] [Abstract][Full Text] [Related]
17. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. Fabrizi F; Takkouche B; Lunghi G; Dixit V; Messa P; Martin P J Viral Hepat; 2007 Oct; 14(10):697-703. PubMed ID: 17875004 [TBL] [Abstract][Full Text] [Related]
18. Impact of hemodialysis therapy on hepatitis C virus infection: a deeper insight. Fabrizi F; Messa P; Martin P Int J Artif Organs; 2009 Jan; 32(1):1-11. PubMed ID: 19241358 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study. Lai TS; Lee MH; Yang HI; You SL; Lu SN; Wang LY; Yuan Y; L'Italien G; Chien KL; Chen CJ; Hepatology; 2017 Sep; 66(3):784-793. PubMed ID: 28370058 [TBL] [Abstract][Full Text] [Related]
20. The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysis. Fabrizi F; Cerutti R; Dixit V; Messa P Nefrologia (Engl Ed); 2020; 40(3):299-310. PubMed ID: 31813592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]